×
Privia Health EBITDA 2020-2025 | PRVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Privia Health ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Privia Health EBITDA 2020-2025 | PRVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Privia Health ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$45.9B
Doximity (DOCS)
$11.3B
Hims & Hers Health (HIMS)
$10.7B
Tempus AI (TEM)
$10B
IRhythm Technologies (IRTC)
$4.3B
Inspire Medical Systems (INSP)
$3.7B
Hinge Health (HNGE)
$3.7B
Schrodinger (SDGR)
$1.7B
Clover Health Investments (CLOV)
$1.6B
Phreesia (PHR)
$1.6B
Enovis (ENOV)
$1.5B
Azenta (AZTA)
$1.4B
10x Genomics (TXG)
$1.4B
Omnicell (OMCL)
$1.3B
Evolent Health (EVH)
$1.1B
Claritev (CTEV)
$705M
Fulgent Genetics (FLGT)
$540M
Veradigm (MDRX)
$498M
Standard BioTools (LAB)
$479M
Butterfly Network (BFLY)
$465M
Talkspace (TALK)
$427M
TruBridge (TBRG)
$337M
Outset Medical (OM)
$310M
Nyxoah SA (NYXH)
$270M
Health Catalyst (HCAT)
$269M
SOPHiA GENETICS SA (SOPH)
$233M
CapsoVision (CV)
$206M
Zepp Health (ZEPP)
$187M
KORU Medical Systems (KRMD)
$160M
Pulmonx (LUNG)
$128M